Index of reports
> Cases with Device Related Infection (1)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Penicillin G where reactions include device related infection. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Penicillin G side effects in 33 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01
Patient: 33 year old male, weighing 93.0 kg (204.6 pounds)
Reactions: Lactobacillus Infection, Blood PH Increased, Tachycardia, Blood PH Decreased, Device Related Infection, Scleral Haemorrhage, Bacterial Sepsis, Acute Respiratory Distress Syndrome, Bone Marrow Failure, Blood Bicarbonate Increased, Acute Respiratory Failure, Renal Failure Acute, Febrile Neutropenia, Haemodialysis, Alopecia, Treatment Failure, Base Excess Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
(Investigational Drug)
Dosage: 60 mg, uid/qd, oral ; 60 mg, uid/qd, oral
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-17
End date: 2012-04-23
(Investigational Drug)
Dosage: 60 mg, uid/qd, oral ; 60 mg, uid/qd, oral
Administration route: Oral
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-02
End date: 2012-04-08
Amphotericin B
Dosage: 450 mg, uid/qd, intravenous (not otherwise specified)
Indication: Fungal Infection
Start date: 2012-05-06
End date: 2012-05-08
Amphotericin B
Dosage: 450 mg, uid/qd, intravenous (not otherwise specified)
Indication: Infection Prophylaxis
Start date: 2012-05-06
End date: 2012-05-08
Aztreonam
Dosage: see image
Indication: Bacterial Infection
Start date: 2012-05-06
End date: 2012-05-07
Aztreonam
Dosage: see image
Indication: Bacterial Infection
Start date: 2012-04-09
End date: 2012-04-10
Caspofungin Acetate
Dosage: see image
Indication: Infection
Start date: 2012-04-09
Caspofungin Acetate
Dosage: see image
Indication: Infection
Start date: 2012-04-08
End date: 2012-04-08
Caspofungin Acetate
Dosage: see image
Indication: Infection
Start date: 2012-05-20
End date: 2012-05-22
Cefepime
Dosage: 2 g, q8 hours, intravenous (not otherwise specified) ; intravenous (not otherwise specified)
Indication: Infection
Start date: 2012-03-29
End date: 2012-04-10
Cefepime
Dosage: 2 g, q8 hours, intravenous (not otherwise specified) ; intravenous (not otherwise specified)
Indication: Infection
Start date: 2012-06-02
End date: 2012-06-05
Cytarabine
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-14
End date: 2012-04-20
Cytarabine
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-30
End date: 2012-04-05
Daunorubicin HCL
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-30
End date: 2012-04-01
Daunorubicin HCL
Dosage: see image
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-14
End date: 2012-04-16
Imipenem and Cilastatin
Dosage: 1000 mg, q8 hours intravenous (not otherwise specified)
Indication: Infection
Start date: 2012-05-07
End date: 2012-05-28
Penicillin G
Dosage: 24000000 u, q24 hrs intravenous (not otherwise specified)
Indication: Infection
Start date: 2012-05-04
End date: 2012-05-09
Vancomycin
Indication: Product Used FOR Unknown Indication
Voriconazole
Dosage: 522 mg, q12 hours, intravenous (not otherwise specified)
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-08
End date: 2012-05-08
Other drugs received by patient: Ondansetron; Seroquel; Percocet; Nystatin; Zyloprim; Acetaminophen; Calcium Carbonate; Lorazepam; Xanax; Allopurinol; Calcium Gluconate; Ibuprofen; Hydroxyzine Pamoate; Celexa
|